ATE63318T1 - Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel. - Google Patents

Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.

Info

Publication number
ATE63318T1
ATE63318T1 AT85114935T AT85114935T ATE63318T1 AT E63318 T1 ATE63318 T1 AT E63318T1 AT 85114935 T AT85114935 T AT 85114935T AT 85114935 T AT85114935 T AT 85114935T AT E63318 T1 ATE63318 T1 AT E63318T1
Authority
AT
Austria
Prior art keywords
plipastatin
production
medicinal products
ala
microbiological methods
Prior art date
Application number
AT85114935T
Other languages
German (de)
English (en)
Inventor
Hamao Umezawa
Takaaki Aoyagi
Tomio Takeuchi
Masa Hamada
Hiroshi Naganawa
Yasuhiko Muraoka
Takaaki Nishikiori
Original Assignee
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found filed Critical Microbial Chem Res Found
Application granted granted Critical
Publication of ATE63318T1 publication Critical patent/ATE63318T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
AT85114935T 1984-12-06 1985-11-26 Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel. ATE63318T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59256475A JPS61134398A (ja) 1984-12-06 1984-12-06 新生理活性物質プリパスタチン及びその製造法

Publications (1)

Publication Number Publication Date
ATE63318T1 true ATE63318T1 (de) 1991-05-15

Family

ID=17293148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85114935T ATE63318T1 (de) 1984-12-06 1985-11-26 Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.

Country Status (13)

Country Link
US (1) US4742155A (enExample)
EP (1) EP0192828B1 (enExample)
JP (1) JPS61134398A (enExample)
KR (1) KR920006881B1 (enExample)
AT (1) ATE63318T1 (enExample)
AU (1) AU583553B2 (enExample)
DE (1) DE3582791D1 (enExample)
DK (1) DK564785A (enExample)
ES (1) ES8701197A1 (enExample)
GR (1) GR852894B (enExample)
HU (1) HU193838B (enExample)
PT (1) PT81615B (enExample)
ZA (1) ZA859315B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
IN167138B (enExample) * 1988-08-17 1990-09-01 Hoechst India
US5619066A (en) * 1990-05-15 1997-04-08 Dallas Semiconductor Corporation Memory for an electronic token
JPH07500814A (ja) * 1991-07-04 1995-01-26 ガーヴァン インスティチュート オブ メディカル リサーチ Ｐｌａ２阻害性化合物
CN1255143A (zh) * 1997-05-09 2000-05-31 阿格拉奎斯特公司 控制植物疾病和黄瓜十二星叶甲的芽孢杆菌新型菌株
CN117683074B (zh) * 2023-12-13 2024-08-16 山东绿邦生物科技有限公司 蜡样芽孢杆菌、蛋白酶抑制剂以及提高蛋白渣产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F

Also Published As

Publication number Publication date
PT81615B (pt) 1988-02-17
AU5030785A (en) 1986-06-12
HU193838B (en) 1987-12-28
HUT40707A (en) 1987-01-28
EP0192828B1 (en) 1991-05-08
GR852894B (enExample) 1986-04-01
EP0192828A3 (en) 1988-06-01
PT81615A (en) 1986-01-01
DK564785A (da) 1986-06-07
JPS61134398A (ja) 1986-06-21
KR860005027A (ko) 1986-07-16
ES8701197A1 (es) 1986-11-16
US4742155A (en) 1988-05-03
DK564785D0 (da) 1985-12-05
AU583553B2 (en) 1989-05-04
EP0192828A2 (en) 1986-09-03
KR920006881B1 (ko) 1992-08-21
ES549565A0 (es) 1986-11-16
DE3582791D1 (de) 1991-06-13
ZA859315B (en) 1986-10-29

Similar Documents

Publication Publication Date Title
NO955219D0 (no) Nye kjemiske forbindelser med PDE-IV-inhiberende aktivitet
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
ES8701733A1 (es) Procedimiento para detectar peroxido de hidrogeno o sustancias formadoras de peroxido de hidrogeno
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
ATE103893T1 (de) 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel.
DE3582791D1 (de) Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.
ES8602725A1 (es) Procedimiento de preparacion de bencensulfonamidas y similares.
HUP9901260A2 (hu) Optikailag aktív fenil-pirimidin-származék mint fájdalomcsillapító szer, eljárás előállítására, ezt tartalmazó gyógyszerkészítmény és intermedierje
ATE44142T1 (de) Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
NO834149L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1-aroyl-5-okso-2-pyrrolidinpropansyrederivater
ES2066605T3 (es) Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.
Yajima et al. Studies on Peptides. IX. Synthesis of N-(Histidylphenylalanylarginy1)-5-methoxytryptamine, an Inhibitor of α-Melanocyte-stimulating Hormone in virto
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
矢島治明 et al. Studies on Peptides. IX. Synthesis of N-(Histidylphenylalanylarginy1)-5-methoxytryptamine, an Inhibitor of α-Melanocyte-stimulating Hormone in virto
Walti Determination of the nature of the volatile base from the rhizome of the pitcher plant Sarracenia Purpurea
MD675B2 (en) The cobalt's complexes with antimicrobic activity and process for manufacturing of them
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
ES8106522A1 (es) Procedimiento para la obtencion de nuevos derivados de 4,7- fenantrolina
KR890014745A (ko) Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물
Pratt et al. Effect of glutathione and some of its components on the response of escherichia coli to penicillin
Bertelli et al. 76 On the activity of γ-amino-butyric-acid derivatives on central nervous system excitability
DK214884D0 (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee